Al18F-NOTA-LM3 PET/CT in Patients With TIO
ConditionTumor-Induced Osteomalacia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorPeking Union Medical College Hospital
About this trial
This is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.
Eligibility criteria
Qualifiers
Patients aged 18 to 80 years.
Suspected or confirmed TIO patients.
Disqualifiers
Combined with other types of tumors.
Severe liver or renal dysfunction (ALT/AST≥5 ULN, GFR<30ml/min).
Pregnant or breast-feeding women.
Inability to perform PET/CT scans.
Trial design
Treatments tested in this trial
- Diagnostic Test: Al18F-NOTA-LM3
- Diagnostic Test: 68Ga-DOTATATE
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov